HROWHarrow Health, Inc.

$1B

Q3 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$49M+43.8% YoY

Gross Profit

$37M75.6% margin

Operating Income

$1M2.7% margin

Net Income

-$4M-8.6% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$352M

Total Liabilities

$294M

Stockholders' Equity

$58M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$34M	+43.8%
Gross Profit	$37M	$24M	+53.9%
Operating Income	$1M	$2M	-24.3%
Net Income	-$4M	-$4M	+3.9%

Revenue Segments

Other Revenue

$228,000100%

HROW Q3 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena